201 related articles for article (PubMed ID: 6183640)
1. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
2. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
[TBL] [Abstract][Full Text] [Related]
3. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
4. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
[TBL] [Abstract][Full Text] [Related]
5. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
6. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
[No Abstract] [Full Text] [Related]
7. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
8. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
Harpel PC; Rosenberg RD
Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
[No Abstract] [Full Text] [Related]
9. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma.
Schmidt B; Mitchell L; Ofosu FA; Andrew M
Thromb Haemost; 1989 Dec; 62(4):1074-7. PubMed ID: 2482548
[TBL] [Abstract][Full Text] [Related]
10. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of factors predisposing to arterial thrombosis in coronary artery disease.
Saxena R; Talwar KK; Kotte VK; Rao YV; Salam SR; Saraya AK
Indian Heart J; 1990; 42(6):433-5. PubMed ID: 1711506
[TBL] [Abstract][Full Text] [Related]
12. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
Fuchs HE; Shifman MA; Pizzo SV
Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
[TBL] [Abstract][Full Text] [Related]
13. [Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin].
Fischer AM; Bros A; Rafowicz S; Josso F
C R Seances Acad Sci D; 1979 Mar; 288(10):887-9. PubMed ID: 89015
[TBL] [Abstract][Full Text] [Related]
14. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):106-14. PubMed ID: 52896
[TBL] [Abstract][Full Text] [Related]
15. Thrombin and haemostasis: regulation of the biological functions of thrombin. (Facts and perspectives).
Machovich R; Horváth I
Haematologia (Budap); 1981 Dec; 14(4):339-59. PubMed ID: 6178655
[TBL] [Abstract][Full Text] [Related]
16. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
Schwarz HP; Aiginger P; Kuzmits R
Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
[TBL] [Abstract][Full Text] [Related]
17. Plasma proteinase inhibitors.
Bodmer JL; Schnebli HP
Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
[TBL] [Abstract][Full Text] [Related]
18. Plasmin inhibitors in different fibrinolytic treatment patterns.
Lasierra J; Diez M; Perera C; Viladés E
Haemostasis; 1981; 10(1):51-62. PubMed ID: 6162721
[TBL] [Abstract][Full Text] [Related]
19. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
